Ildong Holdings

일동홀딩스 · 000230

Health Care Pharmaceuticals · KOSPI

Small-cap

Market cap US$60.8M (₩83.9B)

Overview

Ildong Holdings is a holding company, a parent entity that owns and oversees a group of operating subsidiaries, listed on KOSPI, Korea's main stock exchange.

Its business activities are conducted through those subsidiaries, which operate in the health-care sector, including pharmaceuticals and related services. Because the filing's business description sections contain no substantive detail, the precise products, customers, or supply-chain position of its underlying businesses cannot be confirmed from the available disclosure.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$428.2M

▼ −10.1% YoY

Operating profit · FY2025

US$10.8M

Turned profitable

Net income · FY2025

US$15.6M

▼ −61.2% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$462.6M(₩638.4B)	US$476.5M(₩657.6B)	US$428.2M(₩590.9B)
Operating profit	−US$57.7M(−₩79.6B)	−US$1.7M(−₩2.4B)	US$10.8M(₩14.9B)
Net income	−US$86.1M(−₩118.8B)	US$40.3M(₩55.6B)	US$15.6M(₩21.6B)

Revenue

FY2023US$462.6M
FY2024US$476.5M
FY2025US$428.2M

Operating profit

FY2023−US$57.7M
FY2024−US$1.7M
FY2025US$10.8M

Net income

FY2023−US$86.1M
FY2024US$40.3M
FY2025US$15.6M

Key ratios (FY2025)

ROE

6.2%

Debt/Eq

132.3%

Op. margin

2.5%

Net margin

3.6%

Rev. YoY

▼ −10.1%

Why it matters

As a holding company, Ildong Holdings itself does not directly manufacture or distribute products; its financial results consolidate the performance of its operating subsidiaries.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?